Extended duration of anticoagulation for cancer-associated thrombosis
Tzu-Fei Wang1, Marc Carrier1* 1Department of Medicine, University of Ottawa at the Ottawa Hospital and The Ottawa...
Most Read
Ongoing need for primary prevention of VTE in ambulatory patients with cancer
Nikola Vladic¹, Cihan Ay¹¹Division of Hematology and Haemostaseology, Department of Medicine I, Medical University...
SAVE THE DATE – The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be...
An interview with Grigorios Gerotziafas
ISTH 2018 – Grigorios...
An interview with Raffaella Giavazzi
Raffaella Giavazzi during her 5th Simon Karpatkin Memorial Lecture at the 9th ICTHIC in...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
The COVID-19 outbreak has now spread worldwide, and the number of severe cases is increasing exponentially. Besides the...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
Exploring the Interplay Between Thrombosis and Cachexia in Cancer Patients: Shared Pathophysiology and Clinical Implications
Cancer patients often experience life-threatening complications, such as cancer-associated thrombosis (CAT) and...
PROGRAM AVAILABLE: 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Program available for the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), Bangkok,...
As knowledge increases, wonder deepens
Despite the growing interest in the field of cancer-associated thrombosis (CAT) in the last years, there are still many...